Phase IIb Study of PRO045 in Subjects With Duchenne Muscular Dystrophy
Clinical trial NCT01826474 · TERMINATED
Trial details
- NCT number
- NCT01826474
- Sponsor
- BioMarin Pharmaceutical
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2016-08-31
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.